Management of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age80-130
SponsorUniversitat de Lleida

About this trial

Application of an action protocol focused on the application of non-pharmacological interventions for managing delirium in the process of prevention, diagnosis and treatment, evaluated using an e-health intervention, with a tablet to introduce on it the data about the prevention, diagnostic and treatment process of each recluted patient, in the Igualada Hospital Center, once a day.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age over 80 years

Three risk factor to develop delirium, for example: sex (men), polypharmacy,urinary tract infections (UTIs) or strictures.

Admission in geriatric unit.

Have social support

Disqualifiers

Age under 80 years

Eseeable death on admission not caused by delirium or delirium diagnosis on admission.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Application of an action protocol for the management of delirium through the use of non-pharmacological interventions

    Procedure/Surgery

    The interventions carried out stand out for being non-pharmacological, this avoiding the use of drugs and polypharmacy in elderly patients, avoiding the appearance of clinical complications derived from the side effects that the use of these substances can lead to in the patient. In addition, it also encourages the education of health professionals and nurses' families or caregivers in the management of delirium.

  • Tradicional management of delirium

    Other intervention

    The use of the pharmacological treatment and the mechanical patients restrain were de base of the traditional treatment in deliriums patient in the University hospital of Igualada, because of the less knowledge of the professionals and non-existence protocol of non-pharmacological interventions to management the delirium.

Treatment groups

65 Participants
are divided into 2 treatment groups
Group A: Quantitative study for the evaluation of the protocol's effectivenessExperimental treatment 1 intervention
Group B: Traditional ways to delirium managementActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Rate of patients who develop delirium

It is performed on all patients admitted to geriatric unit with 3 or more risk criteria for the development of delirium. Its measurement is carried out in the morning shift using the Confussional Assesment Scale scale. The score is from 0 to 4 points, with a positive diagnosis being one with a score greater than 2. It compares the incidence of the control group and the intervention group.

Time frame
Its calculation is carried out during the 3 months of the study, and within each particular case, It is carried out in the morning every day, from admission to discharge of the patient, up to 3 days.
2

Rate of patients diagnosed with delirium improving clinical severity

Every patient with a positive diagnostic and an active treatment. The objective is to avaluate the reduction of the symptoms with the Delirium Rating Scale-R-98 scale, in the morning, comparing control gropu and interventional group . The score is from 0 to 48 points, with a positive diagnosis with severity symptoms in scores greater than 12 points.

Time frame
Its calculation is carried out during the three months of the study, and within each particular case, in the morning every day, from the beginning of diagnosis to the improvement of the patient, up to 3 days.
3

Drug use rate for the treatment of delirium

Carried out with the recorded on the e-health program and the observation of the clinical history of each patient who have had a positive diagnosis of delirium in their hospitalitzation in the geriatric unit and has recorded the use of drugs, like number of a day and type of drug, for their treatment. Comparation control group and intervention group.

Time frame
Its calculation is carried out during the 3 months of the study, and within each particular case, in the end of the patient hospitalitzation, up to 3 days.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Universitat de Lleida

Lead sponsor

Hospital d'Igualada

Collaborator

This trial is not recruiting at the moment. You can still explore other options: